These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 15848549)

  • 1. Cyclosporine and rapamycin act in a synergistic and dose-dependent manner in a model of immunosuppressant-induced kidney damage.
    Brook NR; Waller JR; Bicknell GR; Nicholson ML
    Transplant Proc; 2005 Mar; 37(2):837-8. PubMed ID: 15848549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different renal toxicity profiles in the association of cyclosporine and tacrolimus with sirolimus in rats.
    Lloberas N; Torras J; Alperovich G; Cruzado JM; Giménez-Bonafé P; Herrero-Fresneda I; Franquesa Ml; Rama I; Grinyó JM
    Nephrol Dial Transplant; 2008 Oct; 23(10):3111-9. PubMed ID: 18469305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The novel antifibrotic agent pirfenidone attenuates the profibrotic environment generated by calcineurin inhibitors in the rat salt-depletion model.
    Brook NR; Waller JR; Bicknell GR; Nicholson ML
    Transplant Proc; 2005; 37(1):130-3. PubMed ID: 15808571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prograf produces a molecular environment favoring antifibrosis, an effect reversed by the addition of rapamune.
    Brook NR; Waller JR; Bicknell GR; Nicholson ML
    Transplant Proc; 2005; 37(1):148-9. PubMed ID: 15808577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapamycin and cyclosporine have different effects on expression of Ang-1 and Ang-2 and Tie2 in rat renal allograft with chronic allograft nephropathy.
    Ma X; Lu YP; Yang L; Song J; Luo GH; Shi YJ; Li YP
    Transplant Proc; 2008 Oct; 40(8):2804-7. PubMed ID: 18929866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens.
    Dösch AO; Ehlermann P; Koch A; Remppis A; Katus HA; Dengler TJ
    Clin Ther; 2006 Jun; 28(6):893-905. PubMed ID: 16860172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of different immunosuppressants on chronic allograft nephropathy by affecting the transforming growth factor-beta and Smads signal pathways.
    Gao R; Lu Y; Xin YP; Zhang XH; Wang J; Li YP
    Transplant Proc; 2006 Sep; 38(7):2154-7. PubMed ID: 16980029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of transforming growth factor-beta-inducible gene-h3 in normal and cyclosporine-treated rat kidney.
    Sun BK; Li C; Lim SW; Jung JY; Lee SH; Kim IS; Kim YS; Kim J; Bang BK; Yang CW
    J Lab Clin Med; 2004 Mar; 143(3):175-83. PubMed ID: 15007308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic effect of rapamycin and cyclosporin A in the treatment of experimental autoimmune uveoretinitis.
    Martin DF; DeBarge LR; Nussenblatt RB; Chan CC; Roberge FG
    J Immunol; 1995 Jan; 154(2):922-7. PubMed ID: 7814893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of combined rapamycin/cyclosporine on the changes in pro-fibrotic gene expression that occur during the development of allograft vasculopathy in rats, compared with cyclosporine or rapamycin in isolation.
    Murphy GJ; Bicknell GR; Nicholson ML
    Transpl Int; 2003 May; 16(5):347-53. PubMed ID: 12759727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunosuppressant use without bone loss--implications for bone loss after transplantation.
    Goodman GR; Dissanayake IR; Sodam BR; Gorodetsky E; Lu J; Ma YF; Jee WS; Epstein S
    J Bone Miner Res; 2001 Jan; 16(1):72-8. PubMed ID: 11149492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effect of tea polyphenols on transforming growth factor-beta1 expression in rat with cyclosporine A-induced chronic nephrotoxicity.
    Shi SH; Zheng SS; Jia CK; Zhu YF; Xie HY
    Acta Pharmacol Sin; 2004 Jan; 25(1):98-103. PubMed ID: 14704129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of anti-transforming growth factor-beta antibodies in cyclosporine-induced renal dysfunction.
    Islam M; Burke JF; McGowan TA; Zhu Y; Dunn SR; McCue P; Kanalas J; Sharma K
    Kidney Int; 2001 Feb; 59(2):498-506. PubMed ID: 11168932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of urokinase on renal interstitial inflammation in rats with chronic cyclosporine A nephropathy and its possible mechanism].
    Wang Y; Ma L; Tong JR; Luo ZM; He F
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 May; 28(5):835-8. PubMed ID: 18504214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic interactions augment toxicities of sirolimus/cyclosporine combinations.
    Podder H; Stepkowski SM; Napoli KL; Clark J; Verani RR; Chou TC; Kahan BD
    J Am Soc Nephrol; 2001 May; 12(5):1059-1071. PubMed ID: 11316866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FTY720 reduces extracellular matrix expansion associated with ischemia-reperfusion induced injury.
    Delbridge MS; Shrestha BM; Raftery AT; El Nahas AM; Haylor J
    Transplant Proc; 2007 Dec; 39(10):2992-6. PubMed ID: 18089307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapamycin even when combined with cyclosporine attenuates tumor growth but does not induce regression of established walker sarcomas.
    Silva SL; Silva SF; Farias IN; Mota RS; Carvalho RA; Moraes MO; Moraes ME; Campos Hde H
    Transplant Proc; 2004 May; 36(4):934-7. PubMed ID: 15194323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The synergistic effects of cyclosporine, sirolimus, and brequinar on heart allograft survival in mice.
    Tu Y; Stepkowski SM; Chou TC; Kahan BD
    Transplantation; 1995 Jan; 59(2):177-83. PubMed ID: 7839437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic interactions between sirolimus and microemulsion cyclosporine when orally administered jointly and 4 hours apart in healthy volunteers.
    Zimmerman JJ; Harper D; Getsy J; Jusko WJ
    J Clin Pharmacol; 2003 Oct; 43(10):1168-76. PubMed ID: 14517200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct effect of chronic cyclosporine treatment on collagen III mRNA expression and deposition in rat kidneys.
    Ceol M; Anglani F; Vianello D; Murer L; Del Prete D; Forino M; Favaro S; Gambaro G; D'Angelo A
    Clin Nephrol; 2000 Apr; 53(4):suppl 8-9. PubMed ID: 10809427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.